Dr. Mary Tolikas has more than twenty years of professional experience establishing and growing technology-based organisations and companies in both industry and academia.
Dr. Mary Tolikas joined the Wyss Center as Chief Executive Officer in June 2019. She was previously instrumental in the launching and growth of the Wyss Institute for Biologically Inspired Engineering at Harvard University where she spent almost ten years in the leadership team as Operations Director.
During her tenure at Harvard University, she also served as Executive Director for Special Projects at the Office of the Provost and was co-instructor in the Masters in Design Engineering Program, offered by the Harvard John A. Paulson School of Engineering and Applied Sciences and the Harvard Graduate School of Design.
Prior to joining Harvard University, Dr. Mary Tolikas served as Director of Business Development at Ansoft Corporation. Earlier in her career, she held various executive and engineering roles in a number of start-up companies in markets ranging from automotive to medical.
Dr. Mary Tolikas has served in numerous committees and boards but her most rewarding community involvement is mentoring women in science and engineering, as well as entrepreneurs.
She holds a B.Eng. degree in Electrical & Electronics Engineering from the University of Glasgow, Scotland, M.Sc. and Ph.D. degrees in Electrical Engineering & Computer Science from the Massachusetts Institute of Technology and an MBA degree from the Sloan School of Management at MIT.
Study contributes to our understanding of how cocaine withdrawal affects brain circuits
The results could help clinicians understand addiction and enable people to better manage substance withdrawal.Collaboration
Study suggests a promising future for soft bioelectronic interfaces in clinical settings
Results demonstrate MRI compatibility, good surgical handling and reliable recording in bioelectronic interfaces that conform to the nervous system.Technology
Shining a light on neurodegenerative disorders
Could a ray of light stop rogue proteins in their tracks and slow the spread of neurodegenerative disease in the brain? EPFL and the Wyss Center are set to find out.Collaboration